Bushen-Yizhi formula ameliorates cognition deficits and attenuates oxidative stress-related neuronal apoptosis in scopolamine-induced senescence in mice

International Journal of Molecular Medicine

Volumn 34, Issue 2, 2014, Pages 429-439

  Hou, Xue Qin ^a   Wu, Dian Wei ^b   Zhang, Chun Xia ^a   Yan, Rong ^a   Yang, Cong ^a   Rong, Cui Ping ^a   Zhang, Lei ^a   Chang, Xiang ^a   Su, Ru Yu ^a   Zhang, Shi Jie ^a   He, Wen Qing ^a   Qu, Zhao ^a   Li, Shi ^a   Su, Zi Ren ^a   Chen, Yun Bo ^a   Wang, Qi ^a   Fang, Shu Huan ^a  

^a GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^b Shantou Hospital of Traditional Chinese Medicine   (China)

Author keywords

Alzheimer's disease; Antiapoptosis; Antioxidant; Bushen Yizhi formula; Neuroprotection; Scopolamine

Indexed keywords

ACETONITRILE; BUSHEN YIZHI FORMULA; CASPASE 3; CHINESE DRUG; DONEPEZIL; GLUTATHIONE; MALONALDEHYDE; NEUROPROTECTIVE AGENT; PHOSPHORIC ACID; PROTEIN BAX; PROTEIN BCL 2; SCOPOLAMINE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; WATER; BUSHEN YISUI; HERBACEOUS AGENT; SCOPOLAMINE BROMIDE;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CHINESE MEDICINE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG EFFECT; DRUG MEGADOSE; DRUG POTENCY; ENZYME ACTIVITY; FINGER DERMATOGLYPHICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; IMMUNOFLUORESCENCE TEST; LOW DRUG DOSE; MALE; MORRIS WATER MAZE TEST; MOUSE; NERVE CELL; NEUROPROTECTION; NICK END LABELING; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RANDOMIZATION; SENESCENCE; WESTERN BLOTTING; AGING; ANIMAL; CHEMICALLY INDUCED; COGNITION DISORDERS; DRUG EFFECTS; HUMAN; PATHOLOGY; TOXICITY;

AGING; ANIMALS; APOPTOSIS; COGNITION DISORDERS; DRUGS, CHINESE HERBAL; HUMANS; MICE; NEURONS; NEUROPROTECTIVE AGENTS; OXIDATIVE STRESS; SCOPOLAMINE HYDROBROMIDE;

EID: 84904248495     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2014.1801     Document Type: Article

References (39)

1. Pepeu G and Marconcini Pepeu I: Dysfunction of the brain cholinergic system during aging and after lesions of the nucleus basalis of Meynert. J Neural Transm Suppl 44: 189-194, 1994. (Pubitemid 24372897)
2. Schliebs R, Rossner S and Bigl V: Immunolesion by 192IgG-saporin of rat basal forebrain cholinergic system: a useful tool to produce cortical cholinergic dysfunction. Prog Brain Res 109: 253-264, 1996. (Pubitemid 27047095)
3. Niewiadomska G, Baksalerska-Pazera M and Riedel G: The septo-hippocampal system, learning and recovery of function. Prog Neuropsychopharmacol Biol Psychiatry 33: 791-805, 2009.
4. Saykin AJ, Wishart HA, Rabin LA, Flashman LA, McHugh TL, Mamourian AC and Santulli RB: Cholinergic enhancement of frontal lobe activity in mild cognitive impairment. Brain 127: 1574-1583, 2004. (Pubitemid 38899410)
5. Geldmacher DS: Donepezil (Aricept) for treatment of Alzheimer's disease and other dementing conditions. Expert Rev Neurother 4: 5-16, 2004.
6. Gupta R and Gupta LK: Improvement in long term and visuo-spatial memory following chronic pioglitazone in mouse model of Alzheimer's disease. Pharmacol Biochem Behav 102: 184-190, 2012.
7. Richetti SK, Blank M, Capiotti KM, Piato AL, Bogo MR, Vianna MR and Bonan CD: Quercetin and rutin prevent scopolamine-induced memory impairment in zebrafish. Behav Brain Res 217: 10-15, 2011.
8. Knox LT, Jing Y, Fleete MS, Collie ND, Zhang H and Liu P: Scopolamine impairs behavioural function and arginine metabolism in the rat dentate gyrus. Neuropharmacology 61: 1452-1462, 2011.
9. Kwon SH, Lee HK, Kim JA, Hong SI, Kim HC, Jo TH, Park YI, Lee CK, Kim YB, Lee SY and Jang CG: Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via anti-acetylcholinesterase and anti-oxidative activities in mice. Eur J Pharmacol 649: 210-217, 2010.
10. Praticò D: Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows. Ann NY Acad Sci 1147: 70-78, 2008.
11. Choi J, Conrad CC, Malakowsky CA, Talent JM, Yuan CS and Gracy RW: Flavones from Scutellaria baicalensis Georgi attenuate apoptosis and protein oxidation in neuronal cell lines. Biochim Biophys Acta 1571: 201-210, 2002. (Pubitemid 34686922)
12. Zhang H, Liu Y, Lao M, Ma Z and Yi X: Puerarin protects Alzheimer's disease neuronal cybrids from oxidant-stress induced apoptosis by inhibiting pro-death signaling pathways. Exp Gerontol 46: 30-37, 2011.
13. Capurro V, Busquet P, Lopes JP, Bertorelli R, Tarozzo G, Bolognesi ML, Piomelli D, Reggiani A and Cavalli A: Pharmacological characterization of memoquin, a multi-target compound for the treatment of Alzheimer's disease. PLoS One 8: e56870, 2013.
14. Li H, Li SL, Gong L, Wang JL, Li YZ and Wu ZH: The effects of an herbal medicine Bu-Wang-San on learning and memory of ovariectomized female rat. J Ethnopharmacology 117: 427-432, 2008.
15. Zhang GR, Cheng XR, Zhou WX and Zhang YX: Age-related expression of calcium/calmodulin-dependent protein kinase II A in the hippocampus and cerebral cortex of senescence accelerated mouse prone/8 mice is modulated by anti-Alzheimer's disease drugs. Neuroscience 159: 308-315, 2009.
16. Lan Z, Liu J, Chen L, Fu Q, Luo J, Qu R, Kong L and Ma S: Danggui-Shaoyao-San ameliorates cognition deficits and attenuates oxidative stress-related neuronal apoptosis in d-galactose-induced senescent mice. J Ethnopharmacol 141: 386-395, 2012.
17. Li L, Wei HF, Zhang L, Chu J and Zhao L: Modern biological basis of Chinese medical theory that 'kidney nourishes marrow and brain is sea of marrow'. Zhongguo Zhong Yao Za Zhi 31: 1397-1400, 2006 (In Chinese).
18. Howes MJ and Houghton PJ: Plants used in Chinese and Indian traditional medicine for improvement of memory and cognitive function. Pharmacol Biochem Behav 75: 513-527, 2003.
19. Lin HQ, Ho MT, Lau LS, Wong KK, Shaw P and Wan DC: Anti- acetylcholinesterase activities of traditional Chinese medicine for treating Alzheimer's disease. Chem Biol Interact 175: 352-354, 2008.
20. Zhong ZG, Liu MC and Lai SL: Effect of bushen yizhi formula on neurotransmitter release in rat models with Alzheimer disease Chin J Clin Rehabil 44: 167-170, 2005.
21. Chen YB, Lai SL, Hu JQ, Wang Q and Cheng SY: Effects of drug serum in broken bushen yizhi formulas on cell model of Alzheimer disease. Chin J Clin Rehabil 32: 250-253, 2005. (Pubitemid 41574604)
22. Morris R: Developments of a water-maze procedure for studying spatial learning in the rat. J Neurosci Methods 11: 47-60, 1984.
23. Himeno E, Ohyagi Y, Ma L, Nakamura N, Miyoshi K, Sakae N, Motomura K, Soejima N, Yamasaki R, Hashimoto T, Tabira T, LaFerla FM and Kira J: Apomorphine treatment in Alzheimer mice promoting amyloid-β degradation. Ann Neurol 69: 248-256, 2011.
24. Molchan SE, Mellow AM, Hill JL, Weingartner H, Martinez R, Vitiello B and Sunderland T: The effects of thyrotropin-releasing hormone and scopolamine in Alzheimer's disease and normal volunteers. J Psychopharmacol 6: 489-500, 1992. (Pubitemid 23032284)
25. Shi J, Liu Q, Wang Y and Luo G: Coadministration of huperzine A and ligustrazine phosphate effectively reverses scopolamine-induced amnesia in rats. Pharmacol Biochem Behav 96: 449-453, 2010.
26. Jahanshahi M, Nickmahzar EG and Babakordi F: Effect of Gingko biloba extract on scopolamine-induced apoptosis in the hippocampus of rats. Anat Sci Int 88: 217-222, 2013.
27. Kim DH, Jeon SJ, Son KH, Jung JW, Lee S, Yoon BH, Lee JJ, Cho YW, Cheong JH, Ko KH and Ryu JH: The ameliorating effect of oroxylin A on scopolamine-induced memory impairment in mice. Neurobiol Learn Mem 87: 536-546, 2007. (Pubitemid 46505108)
28. Lazareno S, Popham A and Birdsall NJ: Towards a high-affinity allosteric enhancer at muscarinic M1 receptors. J Mol Neurosci 19: 123-127, 2002. (Pubitemid 35013345)
29. Higgins GA, Enderlin M, Fimbel R, Haman M, Grottick AJ, Soriano M, Richards JG, Kemp JA and Gill R: Donepezil reverses a mnemonic deficit produced by scopolamine but not by perforant path lesion or transient cerebral ischaemia. Eur J Neurosci 15: 1827-1840, 2002. (Pubitemid 35471908)
30. Birks J and Harvey RJ: Donepezil for dementia due to Alzheimer"s disease (Review). Cochrane Database of Systematic Reviews: 1, 2006.
31. Takada Y, Yonezawa A, Kume T, Katsuki H, Kaneko S, Sugimoto H and Akaike A: Nicotinic acetylcholine receptor-mediated neuro-protection by donepezil against glutamate neurotoxicity in rat cortical neurons. J Pharmacol Exp Ther 306: 772-777, 2003. (Pubitemid 36886179)
32. Qian YF, Wang H, Yao WB and Gao XD: Aqueous extract of the Chinese medicine, Danggui-Shaoyao-San, inhibits apoptosis in hydrogen peroxide-induced PC12 cells by preventing cytochrome c release and inactivating of caspase cascade. Cell Biol Int 32: 304-311, 2008.
33. Yi LT, Xu Q, Li YC, Yang L and Kong LD: Antidepressant-like synergism of extracts from magnolia bark and ginger rhizome alone and in combination in mice. Prog Neuropsychopharmacol Biol Psychiatry 33: 616-624, 2009.
34. Liu Q, Kou JP and Yu BY: Ginsenoside Rg1 protects against hydrogen peroxide-induced cell death in PC12 cells via inhibiting NF-κB activation. Neurochem Int 58: 119-125, 2011.
35. Qian YH, Han H, Hu XD and Shi LL: Protective effect of ginsenoside Rb1 on beta-amyloid protein(1-42)-induced neurotoxicity in cortical neurons. Neurol Res 31: 663-667, 2009.
36. Cheng Y, Shen LH and Zhang JT: Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta Pharmacol Sin 26: 143-149, 2005. (Pubitemid 40203956)
37. Sun R, Wang K, Wu D, Li X and Ou Y: Protective effect of paeoniflorin against glutamate-induced neurotoxicity in PC12 cells via Bcl-2/Bax signal pathway. Folia Neuropathol 50: 270-276, 2012.
38. Zhang X, Wang J, Xing Y, Gong L, Li H, Wu Z, Li Y, Wang J, Wang Y, Dong L and Li S: Effects of ginsenoside Rg1 or 17β-estradiol on a cognitively impaired, ovariectomized rat model of Alzheimer's disease. Neuroscience 220: 191-200, 2012.
39. 1-42)-injected rats and may be connected to synaptic changes in the hippocampus. Can J Physiol Pharmacol 90: 1446-1455, 2012.